United States spent $162 million on remdesivir development but holds no patents, review finds ...Middle East

Economy by : (Washington Post) -
Members of Congress asked for a GAO review of taxpayer spending that went toward to Gilead's coronavirus drug.

Read More Details
Finally We wish PressBee provided you with enough information of ( United States spent $162 million on remdesivir development but holds no patents, review finds )

Also on site :

Most Viewed Economy
جديد الاخبار